Bergan R - Search Results

1

Gene expression profiling of renal medullary carcinoma: potential clinical relevance.

Yang XJ, Sugimura J, Tretiakova MS, Furge K, Zagaja G, Sokoloff M, Pins M, Bergan R, Grignon DJ, Stadler WM, Vogelzang NJ, Teh BT. Yang XJ, et al. Among authors: bergan r. Cancer. 2004 Mar 1;100(5):976-85. doi: 10.1002/cncr.20049. Cancer. 2004. PMID: 14983493 Free article.

2

In vitro models of prostate apoptosis: clusterin as an antiapoptotic mediator.

Lee C, Janulis L, Ilio K, Shah A, Park I, Kim S, Cryns V, Pins M, Bergan R. Lee C, et al. Among authors: bergan r. Prostate Suppl. 2000;9:21-4. Prostate Suppl. 2000. PMID: 11056498 Review. No abstract available.

3

Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion.

Liu Y, Jovanovic B, Pins M, Lee C, Bergan RC. Liu Y, et al. Oncogene. 2002 Nov 28;21(54):8272-81. doi: 10.1038/sj.onc.1206117. Oncogene. 2002. PMID: 12447690

4

Prostate cancer chemoprevention agents exhibit selective activity against early stage prostate cancer cells.

Liu YQ, Kyle E, Patel S, Housseau F, Hakim F, Lieberman R, Pins M, Blagosklonny MV, Bergan RC. Liu YQ, et al. Among authors: bergan rc. Prostate Cancer Prostatic Dis. 2001;4(2):81-91. doi: 10.1038/sj.pcan.4500506. Prostate Cancer Prostatic Dis. 2001. PMID: 12497043

5

Renal medullary carcinoma and ABL gene amplification.

Simpson L, He X, Pins M, Huang X, Campbell SC, Yang XJ, Perlman EJ, Bergan RC. Simpson L, et al. J Urol. 2005 Jun;173(6):1883-8. doi: 10.1097/01.ju.0000158448.56888.09. J Urol. 2005. PMID: 15879768

6

Phase II study of mitoxantrone and ketoconazole for hormone-refractory prostate cancer.

Eklund J, Kozloff M, Vlamakis J, Starr A, Mariott M, Gallot L, Jovanovic B, Schilder L, Robin E, Pins M, Bergan RC. Eklund J, et al. Cancer. 2006 Jun 1;106(11):2459-65. doi: 10.1002/cncr.21880. Cancer. 2006. PMID: 16615097 Free article. Clinical Trial.

7

Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification.

Ding Y, Xu L, Chen S, Jovanovic BD, Helenowski IB, Kelly DL, Catalona WJ, Yang XJ, Pins M, Ananthanarayanan V, Bergan RC. Ding Y, et al. Among authors: bergan rc. Prostate Cancer Prostatic Dis. 2006;9(4):379-91. doi: 10.1038/sj.pcan.4500888. Epub 2006 Jun 20. Prostate Cancer Prostatic Dis. 2006. PMID: 16786039

8

The methodology used to measure differential gene expression affects the outcome.

Ding Y, Xu L, Jovanovic BD, Helenowski IB, Kelly DL, Catalona WJ, Yang XJ, Pins M, Bergan RC. Ding Y, et al. J Biomol Tech. 2007 Dec;18(5):321-30. J Biomol Tech. 2007. PMID: 18166675 Free PMC article.

9

MEK4 function, genistein treatment, and invasion of human prostate cancer cells.

Xu L, Ding Y, Catalona WJ, Yang XJ, Anderson WF, Jovanovic B, Wellman K, Killmer J, Huang X, Scheidt KA, Montgomery RB, Bergan RC. Xu L, et al. Among authors: bergan rc. J Natl Cancer Inst. 2009 Aug 19;101(16):1141-55. doi: 10.1093/jnci/djp227. Epub 2009 Jul 28. J Natl Cancer Inst. 2009. PMID: 19638505 Free PMC article. Clinical Trial.

10

Androgen receptor-independent function of FoxA1 in prostate cancer metastasis.

Jin HJ, Zhao JC, Ogden I, Bergan RC, Yu J. Jin HJ, et al. Cancer Res. 2013 Jun 15;73(12):3725-36. doi: 10.1158/0008-5472.CAN-12-3468. Epub 2013 Mar 28. Cancer Res. 2013. PMID: 23539448 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters